Life Science Factory to Open a New Location in Munich in 2024
more
Stories about Forschung
Grünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
morePatientGPT from Semalytix Will Replace Six Months of Evidence & Insight Generation in Life Science with Seconds
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreEmpowering the Future of Pain Relief Research: Recipients of the 2023 EFIC-Grünenthal Grant Announced
Brussels/Aachen (ots) - - Three promising early-career scientists have been awarded the prestigious EFIC-Grünenthal Grant (E-G-G) 2023. - The E-G-G funds innovative research projects to advance understanding of pain and improve the lives of people suffering from pain. The European Pain Federation EFIC® and the ...
moreBirth weight and head circumference predict IQ and motor performance at 4 years of age
moreGrünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee
Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
AI against money laundering
moreAmicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
moreGrünenthal and King’s College London collaborate to develop human induced pluripotent stem cell-based microfluidic cultures for pain research
Aachen, Germany and London, England (ots) - - Dr Ramin Raouf from King's College London and Grünenthal strive to develop reliable microfluidic culture models relevant for pain research based on human induced pluripotent stem cell-derived neurons - Grünenthal has expertise in developing human induced pluripotent ...
moreLTS Lohmann Therapie-Systeme AG
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
Andernach, Germany (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”), Oral Thin Films (“OTF”) and Micro Array Patches (“MAP”) announces the signing of the ...
moreGenialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
BOSTON, LAUSANNE & LJUBLJANA, Slovenia (ots) - Debiopharm Innovatoin Fund & Taiwania Capital co-lead financing round for Genialis to propel drug development, diagnostics and treatment planning through AI/ML-enabled platform with a biology-first approach Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, ...
moreDEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCiTM STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne, Switzerland (ots) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and treatment of ...
moreMiltenyi Biotec acquires biosensor company lino Biotech
Zurich (ots) - lino Biotech, a leading biosensor company and the world’s only provider of Focal Molography, announced today it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in bioprocessing, measuring viral load in cell & gene therapy ...
moreThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
moreSwiss Start-Up “Mirai Foods” produces first cultivated tender steak / Breakthrough for Cultivated Premium Beef Steaks
Zurich (ots) - - Three patents for key technologies in “cultivated meat” - Food producer Angst AG takes stake in company - Innovative bioreactor improves efficiency and reduces costs A real new meat experience without sacrifice: Swiss start-up Mirai Foods achieves technological breakthrough for the cultivation ...
moreGreenhouse gas balance for stainless steel production further improved
Dordrecht (ots) - Stainless steel recycling is considered to be a sustainable way to save CO2 in the globally growing steel production. As early as 2010, Fraunhofer UMSICHT researchers determined a savings potential of more than 4.5 t CO2 per ton of blend on behalf of the Oryx Stainless Group. More recent calculations by the UMSICHT team even come to savings of over ...
moreMars Petcare and the Broad Institute create open-access database of dog and cat genomes to advance preventive pet care
New York (ots/PRNewswire) - - The genome database will power ongoing scientific efforts worldwide and help advance individualized pet health care - Insights from this partnership will feed into the MARS PETCARE BIOBANK™, a longitudinal study to understand pet health and disease, transforming pet care for future ...
moreHearing loss company Acousia Therapeutics completes clinical Phase 1 study with its small molecule
Tübingen, Germany (ots) - Hearing loss company Acousia Therapeutics GmbH announced the successful completion of its ACOU085 clinical Phase 1b study today, following the final visit of the last patient treated with the highest ACOU085 dose. ACOU085 is a proprietary small-molecule drug candidate under clinical ...
moreZEISS Academy Africa inaugurated
moreVectorBuilderille merkittävän innovaatiokilpailun ensimmäinen palkinto
Chicago, IL (ots) - --News Direct-- Maailman johtaviin geeninsiirtoteknologiayhtiöihin lukeutuva VectorBuilder Inc. kertoo Guangzhoussa sijaitsevan tuotekehitys- ja valmistuskeskuksensa voittaneen 7. Kiinan Hangzhoussa järjestetyn Chuangke Innovation and Entrepreneurship Global Competition -innovaatiokilpailun. Tämä arvostettu ja korkeatasoinen kilpailu on Kiinan ...
moreVectorBuilder vann första pris i stor innovationstävling
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. - en global ledare inom genleveransteknik - meddelade att deras FoU- och tillverkningscenter i Guangzhou vann mästerskapet i sjunde globala tävlingen i innovation och företagande, som hölls i "Chuangke" Hangzhou, Kina. Denna inflytelserika och mycket konkurrensdrivna tävling är en av de största i Kina och täcker företag i tillväxtstadiet inom alla ...
moredpa Deutsche Presse-Agentur GmbH
Fact-checkers in Germany and Austria launch alliance against disinformation
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
Document protection with colorful barcode / Simple forgery protection for paper documents and PDFs – automated tamper control via app
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
Mechanism for Internet security broken
moreEuropean Society for Medical Oncology (ESMO)
ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...
moreR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
moreTechnische Universität München
New center for digital medicine and health
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37491 Images: https://mediatum.ub.tum.de/1663381 NEWS RELEASE Interdisciplinary research for the digital medicine of the future Federal and state governments approve funding for digital medicine and health center ...
morebenfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
moreEuropean Inventor Award 2022: Meet the inventors that are shaping our world at virtual event
Munich (ots) - - The winners of the European Patent Office’s annual innovation prize will be revealed at a ceremony on 21 June 2022 at 12:00 CEST held in an all-new format - Discover the stories of 14 exceptional inventor teams and 4 young innovators from 14 countries - The public is now invited to vote for their favourite inventor to win the Popular Prize at ...
more
Previous1234Next